Show simple item record

Commentary: Induction Chemotherapy for Head and Neck Cancer: Hypothesis‐Based Rather Than Evidence‐Based Medicine

dc.contributor.authorEisbruch, Avraham
dc.date.accessioned2017-12-15T16:47:55Z
dc.date.available2017-12-15T16:47:55Z
dc.date.issued2007-08
dc.identifier.citationEisbruch, Avraham (2007). "Commentary: Induction Chemotherapy for Head and Neck Cancer: Hypothesis‐Based Rather Than Evidence‐Based Medicine." The Oncologist 12(8): 975-977.
dc.identifier.issn1083-7159
dc.identifier.issn1549-490X
dc.identifier.urihttps://hdl.handle.net/2027.42/139966
dc.publisherAlphaMed Press
dc.publisherWiley Periodicals, Inc.
dc.titleCommentary: Induction Chemotherapy for Head and Neck Cancer: Hypothesis‐Based Rather Than Evidence‐Based Medicine
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHematology and Oncology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/139966/1/onco0975.pdf
dc.identifier.doi10.1634/theoncologist.12-8-975
dc.identifier.sourceThe Oncologist
dc.identifier.citedreferenceHarari PM, Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?. J Clin Oncol. 1997; 15: 2050 – 2055
dc.identifier.citedreferenceWorden FP, Wolf G, Eisbruch A et al. Chemo‐selection of patients for organ preservation in advanced laryngeal cancer: Failure of chemotherapy as the sole treatment for complete histological responders to neoadjuvant chemotherapy. J Clin Oncol. 2006; 24 suppl: 295s
dc.identifier.citedreferenceTannock IF, Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol. 1989; 16: 83 – 101
dc.identifier.citedreferenceRosenthal DI, Pistenma DA, Glatstein E, A review of neoadjuvant chemotherapy for head and neck cancer: Partially shrunken tumors may be both leaner and meaner. Int J Radiat Oncol Biol Phys. 1994; 28: 315 – 320
dc.identifier.citedreferencePosner M, Evolving strategies for combined‐modality therapy for locally advanced head and neck cancer. The Oncologist. 2007; 12: 967 – 974
dc.identifier.citedreferenceToohill RJ, Duncavage JA, Grossmam TW et al. The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies. Laryngoscope. 1987; 97: 407 – 412
dc.identifier.citedreferenceHitt R, Lopez‐Pousa A, Martinez‐Trufero J et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2005; 23: 8636 – 8645
dc.identifier.citedreferenceBaujat B, Audry H, Bourhis J et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta‐analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006; 64: 47 – 56
dc.identifier.citedreferencePignon JP, Bourhis J, Domenge C et al. Chemotherapy added to locoregional treatment for head and neck squamous‐cell carcinoma: Three meta‐analyses of updated individual data. MACH‐NC Collaborative Group. Meta‐Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000; 355: 949 – 955
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.